![Stephen W. Potter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen W. Potter
Corporate Officer/Principal chez APPLIED GENETIC TECHNOLOGIES CORPORATION
Postes actifs de Stephen W. Potter
Sociétés | Poste | Début | Fin |
---|---|---|---|
APPLIED GENETIC TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/01/2015 | - |
Historique de carrière de Stephen W. Potter
Anciens postes connus de Stephen W. Potter
Sociétés | Poste | Début | Fin |
---|---|---|---|
Caladrius Biosciences, Inc.
![]() Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Directeur/Membre du Conseil | 01/01/2013 | 30/07/2013 |
Independent Dir/Board Member | 01/01/2013 | 30/07/2013 | |
Corporate Officer/Principal | 22/07/2013 | 01/02/2015 | |
NeoStem, Inc. /Old/ | Directeur/Membre du Conseil | 01/01/2013 | 01/07/2013 |
Corporate Officer/Principal | 01/07/2013 | 01/02/2015 | |
OSIRIS THERAPEUTICS, INC. | Directeur des opérations | 07/02/2011 | 01/11/2012 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2006 | 01/01/2010 |
Formation de Stephen W. Potter
University of Massachusetts | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Transportation | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Osiris Therapeutics, Inc.
![]() Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Caladrius Biosciences, Inc.
![]() Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Beacon Therapeutics (USA), Inc.
![]() Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
NeoStem, Inc. /Old/ | Transportation |
- Bourse
- Insiders
- Stephen W. Potter
- Expérience